KI-MSC-PL-205
/ Uppsala University
- LARVOL DELTA
Home
Next
Prev
1 to 3
Of
3
Go to page
1
April 26, 2025
ARDS-MSC-205: Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome
(clinicaltrials.gov)
- P1 | N=7 | Active, not recruiting | Sponsor: Uppsala University | Trial completion date: Jun 2025 ➔ Mar 2026
Trial completion date • Acute Respiratory Distress Syndrome • Novel Coronavirus Disease • Pulmonary Disease • Respiratory Diseases
March 04, 2021
ARDS-MSC-205: Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome
(clinicaltrials.gov)
- P1; N=7; Active, not recruiting; Sponsor: Uppsala University; Recruiting ➔ Active, not recruiting
Clinical • Enrollment closed • Acute Respiratory Distress Syndrome • Novel Coronavirus Disease • Respiratory Diseases • CRP • PCR
June 25, 2020
ARDS-MSC-205: Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome
(clinicaltrials.gov)
- P1; N=9; Recruiting; Sponsor: Uppsala University
Clinical • New P1 trial • Acute Respiratory Distress Syndrome • Novel Coronavirus Disease • Respiratory Diseases • CRP • PCR
1 to 3
Of
3
Go to page
1